文献速递糖尿病

实验性非严重低血糖显著损害2型糖尿病患者的认知功能:一项随机交叉试验

Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial.
PubMed 文献 · Diabetologia · 2019-07-31

该随机交叉试验纳入25例2型糖尿病患者,比较低血糖钳夹(血浆葡萄糖3.0±0.2 mmol/l)与正常血糖钳夹(6.0±0.2 mmol/l)对认知功能的影响。结果显示低血糖期间精神运动速度(主要结局)评分降低7.9分(95%CI -10.9, -4.9; p<0.0001),全局认知评分降低0.7分(95%CI -0.9, -0.6; p<0.0001)。结论:急性非严重低血糖(平均血浆葡萄糖3.1 mmol/l)对2型糖尿病患者的认知功能有显著负面影响。

要点

  • 非严重低血糖(平均3.1 mmol/l)即可显著损害2型糖尿病患者的认知功能。
  • 精神运动速度评分在低血糖时降低7.9分,全局认知评分降低0.7分。
  • 年龄、性别、C肽、反调节激素及低血糖症状严重程度未影响认知功能。

核心结论

  • 急性非严重低血糖(平均血浆葡萄糖3.1 mmol/l)对2型糖尿病患者的认知功能产生显著负面影响。

研究设计与样本

  • 随机交叉试验,纳入25例2型糖尿病患者,进行两次高胰岛素钳夹试验:低血糖钳夹(血浆葡萄糖3.0±0.2 mmol/l)和正常血糖钳夹(血浆葡萄糖6.0±0.2 mmol/l)。
  • 参与者纳入标准:年龄35-70岁,BMI 23-35 kg/m2,HbA1c低于75 mmol/mol(9%),糖尿病采用饮食或降糖药物(除外磺脲类或胰岛素)治疗。
  • 认知功能通过神经认知测试组合评估,包括言语记忆、执行功能、持续注意和精神运动速度,并构建全局认知评分;精神运动速度测量为主要结局。

主要发现

  • 低血糖期间主要结局测试(符号数字模式测试,测量精神运动速度)平均得分为48.7±9.8,正常血糖时为56.6±12.0,变化为-7.9分(95%CI -10.9, -4.9; p<0.0001)。
  • 低血糖使全局认知评分降低0.7分(95%CI -0.9, -0.6; p<0.0001)。
  • 神经认知测试期间低血糖钳夹的平均血浆葡萄糖浓度为3.1±0.3 mmol/l。
  • 年龄、性别、空腹C肽、反调节激素及低血糖症状严重程度未影响认知功能。

临床怎么用

  • 对于2型糖尿病患者,即使是非严重低血糖(平均血浆葡萄糖3.1 mmol/l)也应警惕其对认知功能的急性损害。
  • 临床中需关注低血糖对患者日常认知任务(如精神运动速度)的潜在影响,并加强低血糖预防。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Previous studies have demonstrated a relationship between cognitive impairment and hypoglycaemia (<3 mmol/l). This study hypothesised that non-severe insulin-induced hypoglycaemia reduces cognitive function in individuals with type 2 diabetes. METHODS: In this randomised crossover study, 25 participants with type 2 diabetes attended two experimental visits with hyperinsulinaemic glucose clamping: one hypoglycaemic clamp (plasma glucose 3.0 ± 0.2 mmol/l) and one euglycaemic clamp (plasma glucose 6.0 ± 0.2 mmol/l). Participants were eligible if their diabetes was treated with diet or glucose-lowering medications (except sulfonylureas or insulin), age was 35-70 years, BMI was 23-35 kg/m2 and HbA1c was below 75 mmol/mol (9%). Cognitive function was assessed with a neurocognitive test battery measuring verbal memory, executive function, sustained attention and psychomotor speed. From the examined cognitive domains, a global cognition score was constructed estimating global cognition. A measurement for psychomotor speed was selected as the primary outcome. Participants and people assessing the outcomes were blinded to group assignment. RESULTS: Cognitive performance was impaired during hypoglycaemia with a mean score in the primary outcome test, Symbol Digit Modalities Test measuring psychomotor speed, of 48.7 ± 9.8 (hypoglycaemia) vs 56.6 ± 12.0 (euglycaemia); i.e. a change of -7.9 points (95% CI -10.9, -4.9; p < 0.0001). In addition, hypoglycaemia reduced global cognitive score by -0.7 (95% CI -0.9, -0.6; p < 0.0001). A stable glucose plateau was achieved during both experimental visits. For the hypoglycaemic clamp, mean plasma glucose concentration (± SD) during neurocognitive testing was 3.1 (± 0.3) mmol/l. Age, sex, fasting C-peptide, counter-regulatory hormones and the severity of hypoglycaemic symptoms did not influence cognitive function. CONCLUSIONS/INTERPRETATION: Acute non-severe hypoglycaemia (mean plasma glucose 3.1 mmol/l) has a substantial negative impact on cognitive function in individuals with type 2 diabetes. TRIAL REGISTRATION: ClinicalTrials.gov NCT03014011. FUNDING: The study was supported in part by a research grant from the Investigator Initiated Studies Program of Merck Sharp & Dohme Corp (MSD-MA-NORD-007-01). The opinions expressed in this paper are those of the authors and do not necessarily represent those of Merck Sharp & Dohme Corp. Funding was also received from Skibsreder Per Henriksen, R. og hustrus Foundation, The Danish Alzheimer Foundation and Savværksejer Jeppe Juhl og hustrus Foundation.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Nilsson M, Jensen N, Gejl M, et al. Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial. Diabetologia. 2019. PMID: 31367958. doi:10.1007/s00125-019-4964-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。